Policy: Task Masters

Gopal,Kevin;

CONTINUE TO SITE

OR WAIT null SECS

Spotlight

2022 Pharmaceutical Executive APEX Award Winners Pharmaceutical Executive Editorial Staff Update

2022 Pharmaceutical Executive APEX Award WinnersPharmaceutical Executive Editorial Staff Update

Topic

View More Executive Profiles R&D/Clinical Trials Strategy Supply Chain Technology

Executive ProfilesR&D/Clinical TrialsStrategySupply ChainTechnology

News

Media

Pharm Exec Podcasts Pharm Exec Video

Publications

Pharmaceutical Executive

Resources

E-Books Events Sponsored Podcasts Sponsored Videos Webcasts Whitepapers

E-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers

Brand Insights

Enews Magazine

EnewsMagazine

Advertise
Contact Editorial
Editorial Submission Guidelines
Contact MJH Life Sciences
Do Not Sell My Personal Information
Privacy Policy
Terms and Conditions

Spotlight

2022 Pharmaceutical Executive APEX Award Winners
Pharmaceutical Executive Editorial Staff Update

TopicSee All >

Executive Profiles
R&D/Clinical Trials
Strategy
Supply Chain
Technology

Advertise
Contact Editorial
Editorial Submission Guidelines
Contact MJH Life Sciences
Do Not Sell My Personal Information
Privacy Policy
Terms and Conditions

Policy: Task Masters

May 1, 2001

Kevin Gopal

Pharmaceutical Executive

Pharmaceutical Executive, Pharmaceutical Executive-05-01-2001, Volume 0, Issue 0

London-Government and industry have agreed there should be no weakening of patent protection in the effort to speed access to medicines in the developing world.

Related Content:

Pharmaceutical Executive-05-01-2001

Pharmacia's Carrie Cox: HBA Woman of the Year

Friends of Complexity

After the Mad Dash